1. Home
  2. MTH vs LEGN Comparison

MTH vs LEGN Comparison

Compare MTH & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meritage Homes Corporation

MTH

Meritage Homes Corporation

HOLD

Current Price

$66.56

Market Cap

5.1B

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.97

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTH
LEGN
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
5.9B
IPO Year
1988
2020

Fundamental Metrics

Financial Performance
Metric
MTH
LEGN
Price
$66.56
$22.97
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$82.75
$69.58
AVG Volume (30 Days)
772.1K
2.3M
Earning Date
01-28-2026
11-12-2025
Dividend Yield
2.58%
N/A
EPS Growth
N/A
N/A
EPS
7.50
N/A
Revenue
$6,043,594,000.00
$909,045,000.00
Revenue This Year
N/A
$68.83
Revenue Next Year
$5.61
$51.27
P/E Ratio
$8.88
N/A
Revenue Growth
N/A
74.75
52 Week Low
$59.27
$21.19
52 Week High
$84.74
$45.30

Technical Indicators

Market Signals
Indicator
MTH
LEGN
Relative Strength Index (RSI) 39.78 34.78
Support Level $64.85 $21.19
Resistance Level $73.09 $28.97
Average True Range (ATR) 1.71 1.12
MACD -0.72 0.12
Stochastic Oscillator 19.13 23.01

Price Performance

Historical Comparison
MTH
LEGN

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, comprising ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments: homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes, and providing warranty and customer services, and the financial services segment offers title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: